Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (16)
  • 2025 (104)
  • 2024 (99)
  • 2023 (125)
  • 2022 (222)
  • 2021 (128)
  • 2020 (11)
  • 2019 (2)

Subject

  • Drug Trafficking (4125)
  • Synthetic drugs (1103)
  • Guns/Weapons (1015)
  • OCDETF/Task Force (817)
  • Fake Pills (672)
  • Arrests/Convictions - Major (630)
  • Guilty Plea (541)
  • Prescription Drugs (371)
  • Overdose (325)
  • Major Law Enforcement Operation (275)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Pharmaceuticals/Pharmacists/Physicians (227)
  • Money Laundering (210)
  • Gangs (200)
  • Outreach/Drug Prevention (187)
  • Fentanyl Awareness (160)
  • One Pill Can Kill (115)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Counterfeit Pills (30)
  • Asset Forfeiture (29)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Fentanyl Free America (27)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (12)
  • Other (11)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Seizures (Drugs/Property) (473)
  • Diversion Division (253)

Drug Name

  • Fentanyl (282)
  • Methamphetamine (191)
  • Cocaine (170)
  • Heroin (132)
  • Opioids (60)
  • Synthetic Opioids (48)
  • Oxycodone (45)
  • Marijuana (Cannabis) (33)
  • Hydromorphone (18)
  • Benzodiazepines (9)
  • Morphine (9)
  • Ecstasy/MDMA (5)
  • Ketamine (5)
  • Amphetamines (4)
  • Steroids (4)
  • Marijuana Concentrates (3)
  • Methadone (3)
  • Xylazine (3)
  • K2/Spice (2)
  • Synthetic Bath Salts or Designer Cathinones (2)
  • Psilocybin (1)

Field Division

  • Washington, DC (197)
  • Seattle (107)
  • El Paso (51)
  • Houston (39)
  • New England (35)
  • San Francisco (32)
  • New York (31)
  • New Jersey (30)
  • Chicago (29)
  • Atlanta (28)
  • Miami (22)
  • Sede (15)
  • Los Angeles (14)
  • Rocky Mountain (12)
  • Dallas (11)
  • St. Louis (10)
  • New Orleans (9)
  • Phoenix (9)
  • San Diego (9)
  • Omaha (8)
  • Louisville (4)
  • Detroit (3)
Clear All Results
707 Results - Showing 181 to 190
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
PRESS RELEASE

Two Charged with Connection with Scheme to Operate Industrial-Scale Illegal Narcotics Pill Pressing Operations Throughout New York City

Damian Williams, the United States Attorney for the Southern District of New York; Frank A. Tarentino III, the Special Agent in Charge of the New York Division of the Drug Enforcement Administration (“DEA”); and Darren B. McCormack, the Acting Special Agent in Charge of the New York Field Office of...
PRESS RELEASE

Long Island Man Charged with Distributing Fentanyl, Heroin, Cocaine and Oxycodone

Earlier today, at the federal courthouse in Central Islip, a two-count indictment was unsealed charging Ryan Mueller, of Lynbrook, New York, with distributing fentanyl that caused the death of a victim (Victim‑1) and with conspiring to distribute heroin, cocaine, and oxycodone. Mueller was arrested this morning and is scheduled to...
PRESS RELEASE

Three Defendants Arrested During 2023 Joint Enforcement Operation in Carlsbad Plead Guilty to Federal Drug Offenses

ALBUQUERQUE – Three of the eight defendants indicted following a joint enforcement operation last year in Carlsbad, pleaded guilty in federal court to federal drug offenses. Carlos Venegas, Jr., 24, of Carlsbad, pleaded guilty on March 4, 2024, to one count each of conspiracy to distribute 50 grams and more...
PRESS RELEASE

Idaho Doctor Pays $96,000 to Settle Allegations That He Wrote Unlawful Prescriptions

POCATELLO – Dr. Gerald Knouf, a family medicine doctor formerly of Pocatello, Idaho, agreed to pay $96,000 to resolve allegations that he wrote unlawful prescriptions, prescribed dangerous combinations of drugs, and billed Medicare and Medicaid for services that were not performed, U.S. Attorney Josh Hurwit announced today. The settlement also...
PRESS RELEASE

Vernon County Man sentenced to 11 ½ Years for Trafficking Meth and Fentanyl

MADISON, Wis. – John McGarry, Assistant Special Agent in Charge of U.S. Drug Enforcement Administration-Milwaukee and U.S. Attorney Timothy M. O’Shea for the Western District of Wisconsin announced that Stanley J. Holte, 34, Coon Valley, Wisconsin, was sentenced today by U.S. District Judge William M. Conley to 11 ½ years...
PRESS RELEASE

Owner Of New Jersey Company Admits to Evading U.S. Customs Duties and His Company Agrees to a $3.1 Million Settlement Agreement

NEWARK, N.J. – The owner of a New Jersey company today admitted mislabeling hazardous chemicals entering the United States and evading customs duties, DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. George Volpe, 60, of Roseland, New Jersey, owner...
PRESS RELEASE

Idaho Man Sentenced to Over 15 Years in Federal Prison for Possession with Intent to Distribute 10 Pounds of Fentanyl

BOISE, Idaho – Tyler Watson, 40, of Nampa, was sentenced to 188 months in federal prison for possessing ten pounds of fentanyl with intent to distribute it to others, U.S. Attorney Josh Hurwit announced today. According to court records, Watson was a mid-level fentanyl distributor for a large drug trafficking...
PRESS RELEASE

Albuquerque Man Sentenced for Maintaining a Drug-Involved Premises at Motel

ALBUQUERQUE – A federal judge sentenced an Albuquerque man to 57 months in federal prison for maintaining a drug-involved premises in southeast Albuquerque. As the manager of the Best Choice Inn, Kamal Bhula, 44, of Albuquerque, profited from in a kickback scheme that required drug traffickers and users to pay...
PRESS RELEASE

Chemical Importer to Pay $300,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

WACO, Texas – Shrieve Chemical Company, LLC, a Drug Enforcement Administration-registered importer and distributor of listed chemicals, has agreed to pay $300,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act, 21 U.S.C. §§ 801 et seq. In December 2022, DEA diversion investigators conducted...

Paginación

  • Primera página «
  • Anterior
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Current page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster